.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
UBS
Moodys
McKinsey
Express Scripts
Medtronic
QuintilesIMS
Citi
Colorcon
US Department of Justice

Generated: December 18, 2017

DrugPatentWatch Database Preview

MEZLIN Drug Profile

« Back to Dashboard

Which patents cover Mezlin, and what generic alternatives are available?

Mezlin is a drug marketed by Bayer Pharms and is included in four NDAs.

The generic ingredient in MEZLIN is mezlocillin sodium monohydrate. Additional details are available on the mezlocillin sodium monohydrate profile page.
Drug patent expirations by year for MEZLIN

Medical Subject Heading (MeSH) Categories for MEZLIN

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer PharmsMEZLINmezlocillin sodium monohydrateINJECTABLE;INJECTION062333-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer PharmsMEZLINmezlocillin sodium monohydrateINJECTABLE;INJECTION062333-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer PharmsMEZLINmezlocillin sodium monohydrateINJECTABLE;INJECTION062333-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer PharmsMEZLINmezlocillin sodium monohydrateINJECTABLE;INJECTION062372-003May 13, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer PharmsMEZLINmezlocillin sodium monohydrateINJECTABLE;INJECTION062372-002May 13, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer PharmsMEZLINmezlocillin sodium monohydrateINJECTABLE;INJECTION050549-005Mar 2, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer PharmsMEZLINmezlocillin sodium monohydrateINJECTABLE;INJECTION050549-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer PharmsMEZLINmezlocillin sodium monohydrateINJECTABLE;INJECTION062372-005Jan 13, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer PharmsMEZLINmezlocillin sodium monohydrateINJECTABLE;INJECTION050549-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer PharmsMEZLINmezlocillin sodium monohydrateINJECTABLE;INJECTION050549-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Federal Trade Commission
Cantor Fitzgerald
Moodys
Chubb
Medtronic
Fish and Richardson
Cerilliant
Farmers Insurance
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot